Steven Gannon, Director at Xenon Pharmaceuticals Inc. (XENE), sold 13,000 shares at $46.30 ($602K) on 2024-03-07, disclosed to the SEC on 2024-03-08.
Open-market sale of $602k XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.20 | 2,000 | $92K | 15.4% |
| 2 | $46.25 | 5,000 | $231K | 38.4% |
| 3 | $46.30 | 5,000 | $232K | 38.5% |
| 4 | $46.45 | 1,000 | $46K | 7.7% |
| Total | $46.28 avg | 13,000 | $602K | 100% |
| Filing → |
| FUSN | BUY | 2022-08-11 | $180K | — | Filing → |
| FUSN | BUY | 2021-08-23 | $23K | — | Filing → |
| FUSN | BUY | 2021-08-20 | $26K | — | Filing → |